RAYMOND DEBBANE - 13 May 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	LXRX	Stock Option (Right to Buy)	Award	$0	+44,906		$0.000000	44,906	13 May 2024	Common Stock	44,906	$1.79	Direct	F1
transaction	LXRX	Restricted Stock Units	Award	$0	+36,810		$0.000000	36,810	13 May 2024	Common Stock	36,810	$0.000000	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Id	Content
F1	Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.
F2	Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.
F3	Each restricted stock unit represents a contingent right to receive one share of common stock.